pharma · Multiple Myeloma · Not applicable - Healthy volonteers · GPCR
Structure Therapeutics
Structure Therapeutics trial registry — 14 ClinicalTrials.gov studies with program phase, status, and indication context.
601 Gateway Blvd, Suite 900, South San Francisco, California 94080, US HQ
2017 Founded
202 Employees
Public company Type
GPCR · NYSE Ticker
Company details
- Status
- Public
- HQ
- 601 Gateway Blvd, Suite 900, South San Francisco, California 94080, US
- Founded
- 2017
- Employees
- 202
- Programs
- 13
- Drugs
- 7
- Patents
- 93
Structure Therapeutics clinical trials
Registry index of 14 ClinicalTrials.gov studies linked to Structure Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Structure Therapeutics trial registry — 14 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Structure Therapeutics.
-
GSBR-1290-07 — Phase 1
Clinical update -
Aleniglipron — Phase 2
Clinical update -
TG-0054 combined with G-CSF — Phase 2
Clinical update -
GSBR-1290 (Capsule/Tablet) — Phase 1
Clinical update -
Aleniglipron or Placebo — Phase 2
Clinical update -
aleniglipron or placebo — Phase 2
Clinical update -
GPC-100 — Phase 2
Clinical update -
GSBR-1290 — Phase 2
Clinical update